home > pmps > spring 2018 > digital double-win
Pharmaceutical Manufacturing and Packing Sourcer

Digital Double-Win

Today’s pharmaceutical executives navigate extremely complex territory on a daily basis. The toughest quandary they face is existential in nature: how to survive and thrive in the digital economy. Digital developments present both risks – including those connected with business, security, and compliance – and tremendous upside performance transformation opportunities.

Industry headlines are forcing executives to think long and hard about their digital transformation strategies. Consider these sample, thought-provoking headlines:

• Why did CVS buy Aetna for $69 billion? (1)
• Mylan and Teva stocks rise on report about Amazon’s pharmacy aims (2)
• Hearing Amazon’s footsteps, the healthcare industry shudders (3)
• Big Pharma builds blockchain prototype to stop counterfeits (4)
• FDA pushes DSCSA serialisation enforcement deadline to 2018 (5)
• Pharma’s digital supply chain transformation (6)

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
Evren Ozkaya PhD is the Founder and CEO of Supply Chain Wizard: a full-service global consulting firm specialising in serialisation and traceability as well as supply chain strategy and operational transformation programmes. Supply Chain Wizard offers products and services targeting serialisation and supply chain transformation initiatives, along with a team of consultants providing comprehensive support towards cost-effective compliance with serialisation mandates and post-go-live operational support. Email:
Dr Evren Ozkaya
Print this page
Send to a friend
Privacy statement
News and Press Releases

c-LEcta signs Europe sales and distribution agreement with VWR for c-LEcta’s DENARASE®

• DENARASE® is now available through VWR’s sales channels in Europe • VWR, part of Avantor, is a leading global provider of product and service solutions to laboratory and production customers • Cooperation harbors the potential for c-LEcta’s product to gain additional share in a highly dynamic market
More info >>

White Papers

Device Develop for Combo Products


Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>

Industry Events


1-2 November 2018, Gallagher Convention Centre, Midrand, South Africa

The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement